Results 61 to 70 of about 1,315,331 (224)
WATCHMAN (TM) is a left atrial appendage (LAA) occlusion device used to prevent thromboembolism in patients with atrial fibrillation. Endothelialization of the device is required to completely occlude the LAA.
McIvor, Felicity, Wall, Douglas
core +1 more source
Energy‐harvesting‐integrated sensors couple ambient energy conversion with sensing, processing, and wireless communication. This review organizes recent progress through integration architectures and operating principles, revisiting co‐packaged, monolithic, and co‐functional designs together with always‐on, event‐driven, and multi‐modal sensing modes ...
Taehyun Park +5 more
wiley +1 more source
Background: Percutaneous left atrial appendage closure using the WATCHMAN system, to prevent thrombosis and minimize anti-coagulant use in patients with non-valvular atrial fibrillation, has recently been introduced.
Hiroshi Ueno +6 more
core +1 more source
Advancing Energy Materials by In Situ Atomic Scale Methods
Progress in in situ atomic scale methods leads to an improved understanding of new and advanced energy materials, where a local understanding of complex, inhomogeneous systems or interfaces down to the atomic scale and quantum level is required. Topics from photovoltaics, dissipation losses, phase transitions, and chemical energy conversion are ...
Christian Jooss +21 more
wiley +1 more source
Sex-Based Differences In Periprocedural Outcomes Of Left Atrial Appendage Occlusion With The Watchman Device [PDF]
Background/Purpose: Left atrial appendage occlusion (LAAO) is a procedure recommended for individuals with non-valvular atrial fibrillation (NVAF) who have contraindications for long-term anticoagulation. The WATCHMAN is the only FDA approved LAAO device
Arakaki, Andrew Jake
core +1 more source
This review provides a bottom‐up evaluation of sodium‐ion battery safety, linking material degradation mechanisms, cell engineering parameters, and module/pack assembly. It emphasizes that understanding intrinsic material stability and establishing coordinated engineering control across hierarchical levels are vital for preventing degradation coupling ...
Won‐Gwang Lim +5 more
wiley +1 more source
First clinical experience with new left atrial appendage closure device: WATCHMAN FLX® System
Background: Percutaneous left atrial appendage closure (LAAC) with WATCHMAN (WM) has been recognized as a new interventional routine, but the development of device is continuing.
Xin Xue +6 more
doaj +1 more source
How Video‐Based Information Affects Farmers' Willingness to Pay for Drone Services
ABSTRACT Professional service for digital technology like agricultural drones lowers transaction costs and scope thresholds for smallholders. Meanwhile, perceptual adoption barriers remain underexplored. We conduct a two‐stage choice experiment with a randomized video‐based information treatment among 384 Chinese crop farmers to measure its effect on ...
Hua Zhang +4 more
wiley +1 more source
Background Recent publications reached conflicting conclusions about the cost‐effectiveness of left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, Marlborough, MA) for stroke risk reduction in nonvalvular atrial fibrillation
Vivek Y. Reddy +4 more
doaj +1 more source
Cardioform Septal Occluder in the Management of Cardiac Tamponade as a Complication of LAA Closure
Cardiac tamponade is a life-threatening complication during left atrial appendage (LAA) closure. We report a 77-year-old woman who underwent a transseptal puncture for LAA closure with the Watchman device that was complicated by tamponade.
Nabil Braiteh, MD +2 more
doaj +1 more source

